Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research…
Browsing: NHS
Auravia Medical has launched the UK’s first medical cannabis scheme specifically designed for patients on NHS waiting lists, promising priority access to specialist care while waiting…
A quarter of adults in England are living with chronic pain, according to the latest NHS Health Survey for England.The comprehensive study found 26% of adults…
